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Abstract 
This article provides an overview of an approach to incorporating a range of evidence, 
including qualitative research findings, that the authors piloted when developing a clinical 
guideline on epilepsies in children and young people.  We describe methods used for 
incorporating literature types not usually included in Scottish Intercollegiate Guidlines Network 
(SIGN) guidelines, including critical appraisal, and establishing dependability and credibility of 
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qualitative findings. We highlight limitations encountered and make suggestions for future 
work.    
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Background 
Guidelines have traditionally relied on evidence form quantitative studies to make 
recommendations for clinical practice. However, the use of qualitative research as an evidence 
base for generating recommendations has increased in recent years.1 This is due to a range of 
factors including: guideline developers policies paying closer attention to patients’ and carers’ 
perspectives;1 increasing numbers of guidelines on chronic conditions, where patients’ needs 
are important;1 and decision makers increasingly wanting evidence relating to acceptability 
and feasibility of interventions in addition to traditional measures of effectiveness.2 
Lewin and Glenton suggested that the growing use of qualitative evidence to support decision 
making heralds the start of “a new era for qualitative research”;2 this view is supported by the 
use of qualitative evidence by several key guideline development organisations including the 
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World Health Organization (WHO), National Institute of Health and Care Excellence (UK), and 
the Swedish Public Health Institute.2 
The Scottish Intercollegiate Guidelines Network (SIGN) has been producing evidence-based 
clinical guidelines for use in the Scottish National Health Service since 1993.3 SIGN is currently 
developing a guideline on epilepsies in children and young people. During systematic literature 
searching it became clear that two of the guideline’s key questions could not be addressed by 
quantitative evidence alone. We therefore piloted an approach to incorporating a range of 
evidence, including qualitative, in the development of recommendations for these key 
questions. The approach was informed by that taken by Coombs et al4 but adapted to our 
specific circumstances. Here we provide an overview of this approach and suggestions for 
future developments.  
Aims 
To pilot the integration of a range of evidence sources, including qualitative research, in the 
development of a SIGN guideline on epilepsies in children and young people.5 
Approach taken 
Three core principles underpin SIGN’s methodology: (i) guidelines are developed by 
multidisciplinary, nationally representative groups; (ii) literature is systematically reviewed and 
critically appraised, and (iii) recommendations are explicitly linked to the supporting evidence.3 
At the time of writing, SIGN key questions were generally formatted as a quantitative PICO, 
and literature searches framed to identify quantitative evidence.7 
In keeping with SIGN methodology the guideline development group, which comprised 
healthcare professionals, lay representatives and academics, identified several key questions 
to be addressed. Two questions in particular were challenging to answer using quantitative 
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evidence: (i) the process by which transition from paediatric to adult services should take 
place, and (ii) when, where and how discussions about sudden death in epilepsy (SUDEP) 
should take place. 
For the first key question (transition), systematic literature searching identified a high quality 
systematic review on transition from paediatric to adult services,8 in a range of chronic 
conditions but not epilepsy-specific. The search also identified a range of other literature 
sources including scoping and mixed methods reviews, cross-sectional studies and a largely 
descriptive article. These would not traditionally be incorporated in a SIGN guideline; however, 
they contained evidence relevant to the key question and in the absence of epilepsy-specific 
evidence, the guideline development group felt it was important to include them. We applied 
Joanna Briggs Institute (JBI) critical appraisal tools to the cross-sectional and descriptive 
studies.9 We however found a lack of critical appraisal tools specifically for scoping and mixed-
methods reviews and were unable to formally grade their quality. Due to the inclusion of a 
variety of evidence sources it was possible to make conditional recommendations and good 
practice points relating to transition for children and young people with epilepsy, which would 
not have been possible if only high-quality quantitative evidence was eligible. 
For the second key question (SUDEP), the systematic literature search identified mostly 
qualitative studies on patients’, family members’, and healthcare professionals’ perspectives of 
when, where and how discussion should take place. Following initial review of the literature, 
the guideline development group modified the PICO to a qualitative PICo format10 and 
conducted a second search of the literature in order to be comprehensive. A qualitative 
synthesis was initiated11 (ongoing at the time of writing), and a further two qualitative and one 
mixed method studies were identified as relevant to the guideline but outwith the scope of the 
qualitative synthesis. These three studies were critically appraised using JBI tools9 and the first 
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step of the JBI ConQual approach12 was used to establish dependability and credibility of these 
individual studies. With this approach it was possible to make a conditional recommendation 
regarding SUDEP discussions at draft guideline stage; this may however be modified once the 
qualitative synthesis has been fully conducted.  
Discussion 
In this pilot we were able to integrate a range of evidence sources, including qualitative 
evidence, in the development of a clinical guideline on epilepsies in children and young people. 
Our approach to critical appraisal and grading the evidence was informed by JBI systematic 
review methodology; we are confident that this brought rigour to the guideline development 
process. However, our approach is not without limitations. Inclusion of qualitative evidence, in 
the absence of existing qualitative systematic reviews, is a substantial undertaking for a 
guideline development group. Adequate time, resources and expertise needs to be allocated 
for the conduct of novel qualitative syntheses alongside the guideline development process. 
During development of this guideline a series of articles on the GRADE CerQual (Confidence in 
the Evidence from Reviews of Qualitative Research) approach was published,12 and CerQual is 
increasingly being used by guideline developers such as the WHO. GRADE CerQual will be 
applied in our ongoing qualitative synthesis on SUDEP discussion, which will in turn be 
incorporated in the final guideline. Finally, we were unable to apply a structured approach to 
critical appraisal or determining confidence in the findings of some other types of evidence 
(scoping reviews, mixed methods reviews).  
Conclusions 
We believe the inclusion of a range of evidence sources has enhanced the guideline 
development process discussed here. Without this evidence it would be difficult to make 
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recommendations for clinical practice on two important aspects of epilepsy in children and 
young people; with this evidence the perspectives of patients’, family members’ and 
healthcare professionals have informed the guideline (in addition to the perspectives of lay 
members of the guideline development group). There are still some limitations to overcome in 
order to fully integrate this range of evidence in guideline development methodology, and of 
course, the extent to which the recommendations will be easily interpreted and implemented 
by the clinical community is as yet unknown. 
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